Cabergoline and agitation Patient Reports February 12, 2012

Cabergoline Side Effects Report #4634368-8
Cabergoline side effect was reported by a Physician from on Mar 28, 2005. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, cough, fatigue, loss of consciousness. Cabergoline dosage: 2 MG DAILY, ORAL; 4 MG DAILY ORAL; 0.5 MG DAILY, ORAL. During the same period patient was treated with MADOPAR, ENTACAPONE, CLOZAPINE. Patient died on 09/19/2004.

Cabergoline Side Effects Report #4656540-3
Cabergoline side effect was reported by a Physician from on Apr 22, 2005. Male patient, 84 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, cough, loss of consciousness. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, ENTACAPONE, CLOZAPINE. Patient died on 09/19/2004.

Cabergoline Side Effects Report #5564115-7
Cabergoline side effect was reported by a Consumer or non-health professional from SPAIN on Dec 05, 2007. Female patient, 81 years of age, was diagnosed with parkinson's disease , pneumonia  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, chorea, confusional state, disorientation, dyskinesia, hallucination, pneumonia . Cabergoline dosage: DAILY DOSE:6MG. During the same period patient was treated with ERYTHROMYCIN, HALAZEPAM, AMLODIPINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4960898-5
Cabergoline side effect was reported by a Physician from JAPAN on Mar 13, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, delusion, hallucination, visual, insomnia, motor dysfunction, neuroleptic malignant syndrome, screaming. Cabergoline dosage: (2 MG,), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA W, AMANTADINE, PRAMIPEXOLE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4968280-1
Cabergoline side effect was reported by a Physician from JAPAN on Mar 28, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, excitability, hallucination, visual, insomnia, motor dysfunction, persecutory delusion, refusal of treatment by patient, screaming. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA W, AMANTADINE, PRAMIPEXOLE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4984310-5
Cabergoline side effect was reported by a Physician from SPAIN on Apr 07, 2006. Male patient, 74 years of age, weighting 143.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, hallucination, psychomotor hyperactivity. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMLODIPINE, LEVODOPA. Patient recovered.

Cabergoline Side Effects Report #5118559-8
Cabergoline side effect was reported by a Physician from AUSTRALIA on Sept 14, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, hallucinations, mixed. Cabergoline dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LITHIUM, ENDEP, OROXINE, PRESSIN, LITHICARB. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4985759-7
Cabergoline side effect was reported by a Physician from JAPAN on Apr 10, 2006. Female patient, 62 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abnormal behaviour, affect lability, agitation, akinesia, amnesia, blood creatine phosphokinase increased, bradyphrenia, catatonia, condition aggravated. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with SELEGILINE, ZONISAMIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5942597-6
Cabergoline side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 23, 2008. Female patient, 32 years of age, was diagnosed with hyperprolactinaemia and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, psychotic disorder . Cabergoline dosage: (0.5 MG 2X/WEEK). During the same period patient was treated with AMISULPRIDE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #5191642-7
Cabergoline side effect was reported by a Physician from JAPAN on Dec 06, 2006. Male patient, 81 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: affect lability, agitation, anxiety , cardiovascular disorder, cerebral atrophy, cognitive disorder, delirium, dementia , disorientation. Cabergoline dosage: 50 MG, ORAL. During the same period patient was treated with TANDOSPIRONE CITRATE, DONEPEZIL, LEVODOPA, QUETIAPINE FUMARATE, TIAPRIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.